Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V95.8.2637.008K07_2637_2644PMID 10753845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenesis spectrum in the stroma of B‐cell non‐Hodgkin's lymphomas. An immunohistochemical and ultrastructural study

  2009cited by this paper
• Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma

  2004cited by this paper
• Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.

  1999cited by this paper
• Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

  1999cited by this paper
• Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.

  1999cited by this paper
• Plasminogen activator in acute myeloid leukaemic marrows: u‐PA in contrast to t‐PA in normal marrow

  1998cited by this paper
• Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models.

  1998cited by this paper
• Vascular enumeration as a significant prognosticator for invasive breast carcinoma.

  1998cited by this paper
• Acute lymphoblastic leukemia.

  1998cited by this paper
• Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density.

  1998cited by this paper
• Delivery of Molecular and Cellular Medicine to Solid Tumors

  1997cited by this paper
• Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.

  1997cited by this paper
• Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.

  1997cited by this paper
• Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.

  1997cited by this paper
• Halting angiogenesis suppresses carcinoma cell invasion

  1997cited by this paper
• The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors.

  1997cited by this paper
• Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines.

  1996cited by this paper
• Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis

  1996cited by this paper
• Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis.

  1996cited by this paper
• The microtubule-affecting drug paclitaxel has antiangiogenic activity.

  1996cited by this paper
• Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

  1995cited by this paper
• Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts.

  1995cited by this paper
• Transformation of sinusoids into capillaries in a rat model of selenium‐induced nodular regenerative hyperplasia: An immunolight and immunoelectron microscopic study

  1995cited by this paper
• Tumor angiogenesis as a predictor of recurrence in gastric carcinoma.

  1995cited by this paper
• Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study.

  1995cited by this paper
• Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.

  1995cited by this paper
• Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.

  1995cited by this paper
• Tumor angiogenesis as a prognostic factor in cervical carcinoma.

  1995cited by this paper
• Angiogenesis and breast cancer metastasis.

  1995cited by this paper
• Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.

  1994cited by this paper
• Bone marrow angiogenesis and progression in multiple myeloma

  1994cited by this paper
• Tumor angiogenesis in human lung adenocarcinoma

  1994cited by this paper
• Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair.

  1994cited by this paper
• Inhibition of Angiogenesis by Anthracyclines and Titanocene Dichloride a

  1994cited by this paper
• Studies on capillarization of the hepatic sinusoids in alcoholic liver disease.

  1993cited by this paper
• Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma

  1993cited by this paper
• Capillarization and venularization of hepatic sinusoids in porcine serum‐induced rat liver fibrosis: A mechanism to maintain liver blood flow

  1993cited by this paper
• Vinca alkaloids: anti-vascular effects in a murine tumour.

  1993cited by this paper
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

  1993cited by this paper
• Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis.

  1992cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• The role of capillarization in hepatic failure: Studies in carbon tetrachloride‐induced cirrhosis

  1991cited by this paper
• Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

  1990cited by this paper
• Induction of angiogenesis during the transition from hyperplasia to neoplasia

  1989cited by this paper
• Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors.

  1987cited by this paper
• High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.

  1987cited by this paper
• Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture

  1986cited by this paper
• Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

  1985cited by this paper
• Monoclonal antibodies to blood group isoantigens: An alternative marker to factor VIII related antigen for benign and malignant vascular endothelial cells

  1985cited by this paper
• Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta

  1985cited by this paper
• Endothelial proliferation in tumours and normal tissues: continuous labelling studies.

  1984cited by this paper
• Acute lymphoblastic leukemia.

  1982cited by this paper
• Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method.

  1980cited by this paper
• TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION

  1972cited by this paper

• A human pathophysiological 3D-bone marrow model reveals immune and stromal cell heterogeneity

  2026cites this paper
• Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope.

  2026cites this paper
• Ferritin in Acute Myeloid Leukemia: Not Only a Marker of Inflammation and Iron Overload, but Also a Regulator of Cellular Iron Metabolism, Signaling and Communication

  2025cites this paper
• Leukemia cells remodel bone marrow stromal cells to generate a protumoral microenvironment via the S100A8-NOX2-ROS signaling pathway

  2025cites this paper
• Leukemia-expanded splenic CD81+ erythroblasts potentiate disease progression in mice by reshaping leukemic cell metabolism

  2025cites this paper
• Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia

  2025cites this paper
• Semaphorins and the bone marrow microenvironment: New candidates that influence the hematopoietic system.

  2024cites this paper
• IL-2/CD25 axis mediates cellular networks promoting the growth of CD25+ acute myeloid leukemia cells

  2024cites this paper
• Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study

  2024cites this paper
• Inhibition of TGF-β signaling in bone marrow endothelial cells promotes hematopoietic recovery in acute myeloid leukemia patients.

  2024cites this paper
• Dynamic Localization of Leukemia Stem Cells via CXCL12 Regulates Leukemia Progression

  2024cites this paper
• Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression

  2024cites this paper
• Moojecin: The first disintegrin from Bothrops moojeni venom and its antitumor activity in acute myeloid leukemia.

  2024cites this paper
• Endothelial heterogeneity in bone marrow: insights across development, adult life and leukemia

  2024cites this paper
• Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression

  2024cites this paper
• The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors

  2024cites this paper
• The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML)

  2023cites this paper
• Role of the bone marrow vascular niche in chemotherapy for MLL-AF9-induced acute myeloid leukemia

  2023cites this paper
• Study of significance of bone marrow microvessel density in myeloproliferative neoplasms in correlation with CD34 blasts, mast cell count and fibrosis

  2023cites this paper
• Hematopoietic Stem Cells and Their Bone Marrow Niches.

  2023cites this paper
• Endothelial cells: major players in acute myeloid leukaemia.

  2022cites this paper
• Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches

  2022cites this paper
• A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies

  2022cites this paper
• A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy

  2022cites this paper
• Establishment of Prognosis Model in Acute Myeloid Leukemia Based on Hypoxia Microenvironment, and Exploration of Hypoxia-Related Mechanisms

  2021cites this paper
• Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance

  2021cites this paper
• Dynamic contrast-enhanced magnetic resonance imaging quantification of leukemia-induced changes in bone marrow vascular function

  2021cites this paper
• The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid Malignancy

  2021cites this paper
• Total Matrix Metalloproteinase-2 and Prostaglandin E2 as Potential Biomarkers in Iraqi AML Patients

  2021cites this paper
• The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities

  2021cites this paper
• Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis

  2021cites this paper
• Leukaemia: a model metastatic disease

  2021cites this paper
• Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial

  2021cites this paper
• DCE-MRI quantification of leukemia-induced changes in bone marrow vascular function.

  2021cites this paper
• The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia

  2021cites this paper
• Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort

  2021cites this paper
• Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients

  2020cites this paper
• Anti-angiogenic activity of ShengMaBieJia decoction in vitro and in acute myeloid leukaemia tumour-bearing mouse models

  2020cites this paper
• Evaluation of Hepatocyte Growth Factor in Iraqi Patients with Acute Myeloid Leukemia: Its Correlation with Clinical Parameters and Response to Induction Therapy

  2020cites this paper
• The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia

  2020cites this paper
• The extracellular matrix: A key player in the pathogenesis of hematologic malignancies.

  2020cites this paper
• Insights into the mechanism of Arnebia euchroma on leukemia via network pharmacology approach

  2020influential citation
• Cell interactions in the bone marrow microenvironment affecting myeloid malignancies.

  2020cites this paper
• Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia

  2020cites this paper
• Angiogenesis in acute myeloid leukemia

  2020cites this paper
• The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies

  2020cites this paper
• Efficacy and Safety of Metronomic Chemotherapy Versus Palliative Hydroxyurea in Unfit Acute Myeloid Leukemia Patients: A Multicenter, Open-Label Randomized Controlled Trial

  2020cites this paper
• The role of vasculature in cancer stem cell niches

  2020cites this paper
• 7-Difluoromethyl-5,4′-dimethoxygenistein exerts anti-angiogenic effects on acute promyelocytic leukemia HL-60 cells by inhibiting the TLR4/NF-κB signaling pathway

  2020cites this paper
• Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models

  2020cites this paper
• Human fibronectin extra domain B as a biomarker for targeted therapy in cancer

  2020cites this paper
• Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)

  2019cites this paper
• Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment

  2019cites this paper
• Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.

  2019cites this paper
• Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis

  2019cites this paper
• Hypoxia-Inducible Factor 1-Α (HIF1α) and Vascular Endothelial Growth Factor-A (VEGF-A) Expression in De Novo AML Patients

  2019cites this paper
• Correlation of histological marrow characteristics and intravoxel incoherent motion-derived parameters in benign and malignant hematological disorders.

  2019cites this paper
• Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure.

  2019cites this paper
• Role of Endoglin Expression in Acute Myeloblastic Leukemia

  2019cites this paper
• The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia

  2019cites this paper
• The Expression of the SLIT–ROBO Family in Adult Patients with Acute Myeloid Leukemia

  2019cites this paper
• Stem cell damage after chemotherapy- can we do better?

  2019cites this paper
• Vascularized Microfluidics and the Blood–Endothelium Interface

  2019cites this paper
• Overexpression of heme oxygenase‐1 in microenvironment mediates vincristine resistance of B‐cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion

  2019cites this paper
• Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML

  2018cites this paper
• The Changes of the Levels of Tumor Necrosis Factor α, Interferon γ and Vascular Endothelial Growth Factor in the Sera of Children with Acquired Aplastic Anemia after Blood Transfusion

  2018cites this paper
• Targeted drug delivery for tumor therapy inside the bone marrow.

  2018cites this paper
• Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis

  2018cites this paper
• 内皮细胞靶向的可溶性Notch配体hD1R蛋白对急性髓系白血病细胞增殖的影响

  2018cites this paper
• Endothelin receptor emerges as a potential target of Hoxa9-mediated leukemogenesis.

  2018cites this paper
• Hematopoiesis and microenvironment in hematological malignancies

  2018cites this paper
• Nanomedicines for the treatment of hematological malignancies

  2018cites this paper
• IL-2/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells.

  2018cites this paper
• Acute Myeloid Leukemia and the Bone Marrow Niche—Take a Closer Look

  2018cites this paper
• Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation

  2017influential citation
• Hematopathological alterations of major tumor suppressor cascade, vital cell cycle inhibitors and hematopoietic niche components in experimental myelodysplasia.

  2017cites this paper
• Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis

  2017cites this paper
• Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia

  2017influential citation
• Therapy of older persons with acute myeloid leukaemia.

  2017cites this paper
• Increased expression of platelet derived growth factor receptor β on trephine biopsies correlates with advanced myeloma.

  2017cites this paper
• University of Groningen Clinical and biological aspects of Multiple Myeloma

  2017cites this paper
• Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells

  2017cites this paper
• Integration of hypoxic HIF-α signaling in blood cancers

  2017cites this paper
• Treatment of Acute Myelogenous Leukemia

  2017cites this paper
• The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression.

  2017cites this paper
• Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor.

  2017cites this paper
• Some Reasons to Deeper Investigate the Vascular Niche in Acute Myeloid Leukemia

  2017cites this paper
• A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular niche

  2017cites this paper
• The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients.

  2017cites this paper
• Evaluation of Bone Marrow Microvessel Density in Patients with Aplastic Anemia

  2017cites this paper
• Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy

  2017cites this paper
• Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199

  2017influential citation
• The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications.

  2017cites this paper
• MRI Study on the Changes of Bone Marrow Microvascular Permeability and Fat Content after Total-Body X-Ray Irradiation

  2017cites this paper
• three-dimensional vivo model mimics cell-cell

  2017cites this paper
• Naringin inhibits vascular endothelial cell apoptosis via endoplasmic reticulum stress- and mitochondrial-mediated pathways and promotes intraosseous angiogenesis in ovariectomized rats

  2017cites this paper
• Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations

  2017cites this paper
• Endothelial progenitor cells in hematologic malignancies.

  2016cites this paper
• Study of Plasma Endostatin Level in Patients with Acute MyeloidLeukemia

  2016cites this paper
• Molecular dysfunctions in acute myeloid leukemia revealed by integrated analysis of microRNA and transcription factor.

  2016cites this paper